251 related articles for article (PubMed ID: 25477565)
1. Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?
Kiser TH
Hosp Pharm; 2014 Nov; 49(10):923-41. PubMed ID: 25477565
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
Kiser TH
Hosp Pharm; 2013 Sep; 48(5 Suppl):S2-S9. PubMed ID: 35694374
[TBL] [Abstract][Full Text] [Related]
3. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm.
Ehtisham A; Taylor S; Bayless L; Samuels OB; Klein MW; Janzen JM
South Med J; 2009 Feb; 102(2):150-3. PubMed ID: 19139684
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
5. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
6. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
7. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
Wu CT; Wong CS; Yeh CC; Borel CO
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
[TBL] [Abstract][Full Text] [Related]
9. Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage.
Weant KA; Ramsey CN; Cook AM
Pharmacotherapy; 2010 Apr; 30(4):405-17. PubMed ID: 20334460
[TBL] [Abstract][Full Text] [Related]
10. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature.
Velat GJ; Kimball MM; Mocco JD; Hoh BL
World Neurosurg; 2011 Nov; 76(5):446-54. PubMed ID: 22152574
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
Haley EC; Kassell NF; Torner JC
J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
[TBL] [Abstract][Full Text] [Related]
13. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
Liu-Deryke X; Rhoney DH
Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
[TBL] [Abstract][Full Text] [Related]
14. Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.
Dabus G; Nogueira RG
Interv Neurol; 2013 Oct; 2(1):30-51. PubMed ID: 25187783
[TBL] [Abstract][Full Text] [Related]
15. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
[TBL] [Abstract][Full Text] [Related]
16. [Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage].
Raabe A; Beck J; Berkefeld J; Deinsberger W; Meixensberger J; Schmiedek P; Seifert V; Steinmetz H; Unterberg A; Vajkoczy P; Werner C;
Zentralbl Neurochir; 2005 May; 66(2):79-91. PubMed ID: 15846536
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
Lanzino G; Kassell NF
J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based cerebral vasospasm management.
Weyer GW; Nolan CP; Macdonald RL
Neurosurg Focus; 2006 Sep; 21(3):E8. PubMed ID: 17029347
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
Hänggi D; Beseoglu K; Turowski B; Steiger HJ
Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
[TBL] [Abstract][Full Text] [Related]
20. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
